6 kombination med et godkendt stof, der er aktivt imod fluoroquinolon- resistent N. gonorrhoeae, eller i tilfælde af anden fejlslagen behandling.
6 The CHMP considered that due to the emergence of fluoroquinolone-resistant N. gonorrhoeae strains moxifloxacin should not be used in empirical monotherapy of mild to moderate PID, unless a resistance against moxifloxacin can be ruled out.